Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pain × Cannabidiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Sturge-Weber Syndrome 2 Neoplasms 2 Nausea 2 Marijuana Abuse 2 Colonic Neoplasms 2 Anxiety Disorders 2 Vomiting 1 Solid Tumor 1 Parasomnias 1 Pain 1 Glioblastoma 1 Dysgeusia 1 Drug Resistant Epilepsy 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Cachexia 1 Breast Carcinoma In Situ 1 Breast Cancer Female 1 Arthralgia 1 Appetitive Behavior 1

Interventions

Surveys and Questionnaires 14 Acupuncture Therapy 14 Fentanyl 12 Acetaminophen 12 Lidocaine 11 Analgesia 11 Morphine 10 Ketamine 10 Therapeutics 9 Ropivacaine 9 Methadone 9 Bupivacaine 9 Psychiatric Rehabilitation 8 Oxycodone 7 Hydromorphone 7 Water 5 Radiotherapy 5 Music Therapy 5 Methods 5 Early Intervention, Educational 5 Control Groups 5 Zoledronic Acid 4 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Saline Solution 4 Electroacupuncture 4 Colonoscopy 4 Calcium Dobesilate 4 Analgesics, Opioid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡